Study of Regorafenib as a 3rd-line or Beyond Treatment for Gastrointestinal Stromal Tumors (GIST)
Clinical trial NCT01271712 · COMPLETED
Trial details
- NCT number
- NCT01271712
- Sponsor
- Bayer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-04
- Primary completion
- 2012-01-26
- Enrollment
- 199
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.